Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?

Leukemia
Kiran TawanaJane E Churpek

Abstract

Comprehensive genomic profiling of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) cases have enabled the detection and differentiation of driver and subclonal mutations, informed risk prognostication, and defined targeted therapies. These insights into disease biology, and management have made multigene-acquired mutation testing a critical part of the diagnostic assessment of patients with sporadic MDS and AML. More recently, our understanding of the role of an increasing number of inherited genetic factors on MDS/AML risk and management has rapidly progressed. In recognition of the growing impact of this field, clinical guidelines and disease classification systems for both MDS and AML have recently incorporated familial MDS/AML predisposition syndromes into their diagnostic algorithms. In this perspective piece, we contemplate the advantages, disadvantages, and barriers that would need to be overcome to incorporate inherited MDS/AML genetic testing into the upfront molecular diagnostic work-up of every MDS/AML patient. For centers already performing panel-based tumor-only testing, including genes associated with familial forms of MDS/AML (e.g., RUNX1, CEBPA, GATA2, TP53), we advocate optimizing these tests to...Continue Reading

References

Apr 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN American Society of Clinical Oncology
Apr 17, 2003·Cytogenetic and Genome Research·M GrossH Hoehn
Mar 30, 2007·The New England Journal of Medicine·Mary Y ArmaniosJames E Loyd
Sep 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas PabstBeatrice U Mueller
Nov 15, 2013·Blood·Michael A SpinnerSteven M Holland
Jun 4, 2014·Annals of Medicine·David B WilsonMonica Bessler
Apr 30, 2015·Cancer Cell·Chantana PolprasertJaroslaw P Maciejewski
Jun 9, 2015·Bone Marrow Transplantation·R Peffault de LatourUNKNOWN Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation
Jul 19, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey KimRichard Pazdur
Sep 2, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E RobsonNoralane M Lindor
Apr 7, 2016·The New England Journal of Medicine·John P DeVincenzoJohn Fry
Apr 7, 2016·The New England Journal of Medicine·Reuben Arasaratnam
Jun 9, 2016·The New England Journal of Medicine·Elli PapaemmanuilPeter J Campbell
Jul 20, 2016·The New England Journal of Medicine·Colin C PritchardPeter S Nelson
Jul 30, 2016·Blood·UNKNOWN University of Chicago Hematopoietic Malignancies Cancer Risk Team
Dec 14, 2016·The New England Journal of Medicine·John S WelchTimothy J Ley
Jan 20, 2017·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Hideki MuramatsuSeiji Kojima
Feb 9, 2017·The New England Journal of Medicine·R Coleman LindsleyBenjamin L Ebert
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elissa Furutani, Akiko Shimamura
Jun 8, 2017·Blood·Eytan M SteinMartin S Tallman
Jun 24, 2017·Seminars in Hematology·Anna L BrownLucy A Godley
Jun 24, 2017·The New England Journal of Medicine·Richard M StoneHartmut Döhner

❮ Previous
Next ❯

Citations

Dec 7, 2018·Hematology·Gregory W Roloff, Elizabeth A Griffiths
Jun 30, 2019·European Journal of Haematology·Teresa D'AltriBo T Porse
Apr 6, 2019·Journal of Clinical Pathology·Grazia FazioGiovanni Cazzaniga
Dec 22, 2019·British Journal of Haematology·Sarah CharrotJude Fitzgibbon
May 18, 2020·International Journal of Molecular Sciences·Cosimo CumboFrancesco Albano
Sep 28, 2018·Current Hematologic Malignancy Reports·Imo J AkpanLucy A Godley
Aug 19, 2020·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Gregory W RoloffMichael W Drazer
Nov 15, 2018·Blood Advances·Gregory W Roloff, Elizabeth A Griffiths
Dec 13, 2019·The Journal of International Medical Research·Bixia LiQitian Mu
Oct 18, 2019·British Journal of Haematology·Laura PalomoUNKNOWN Spanish Group of MDS (GESMD)
Feb 2, 2019·The Journal of Clinical Investigation·Jane E Churpek, Emery H Bresnick
Jan 5, 2021·Current Opinion in Hematology·Lucy A Godley
Jun 9, 2021·Human Molecular Genetics·Simone FeursteinLucy A Godley

❮ Previous
Next ❯

Methods Mentioned

BETA
MDS

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.